Investor Relations

Upcoming Events

2019 Annual Meeting of Stockholders

Jun 13, 2019 • 10:00am EDT

View All Events

Latest Financial Results

FY 2018

Fiscal Year Ended Dec 31, 2018

Latest Annual Filing

Fiscal Year Ended Dec 31, 2018

View Filing

Stock Information

Company Overview

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology.

The company's patented technology allows for creation of miniature transducers that transmit low-frequency, low-intensity ultrasound through flexible material surfaces. This unique platform may be utilized for a variety of medical applications requiring low cost therapeutic ultrasound qualities.

The company's patch-based products include the PainShield® and the WoundShield™, which have gained CE Mark certification. The PainShield also carries FDA clearance. NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.

The Company was founded by Jona Zumeris, Ph.D., an accomplished scientist that invented the Company’s proprietary low-intensity, surface acoustic wave technology, which allowed it to develop the first ever wearable therapeutic ultrasound devices.

Leadership

Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Investor Contact Information

Company

NanoVibronix, Inc.
525 Executive Boulevard
Elmsford, NY 10523

Investor Relations

Crescendo Communications
T: 212-671-1021
naov@crescendo-ir.com

Transfer Agent

VStock Transfer, LLC
T: 212-828-8436
info@vstocktransfer.com

Ask Us